Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10023626 Polynucleotides encoding immune modulating polypeptides

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 30, 2014
0
Date of Patent
July 17, 2018
0
Patent Application Number
15025994
0
Patent Citations Received
‌
US Patent 10844087 Method of suppressing formation of photocrosslink, and photoreactive nucleic acid in which auto-crosslink formation is suppressed
‌
US Patent 11696946 Influenza vaccine
0
‌
US Patent 11744801 Methods of making lipid nanoparticles
‌
US Patent 11752206 Herpes simplex virus vaccine
‌
US Patent 11767548 RNA polymerase variants
‌
US Patent 12070495 HIV RNA vaccines
0
‌
US Patent 11786607 RNA formulations
‌
US Patent 11359197 Antisense oligonucleotides targeting alpha-synuclein and uses thereof
‌
US Patent 11447775 Antisense oligonucleotides targeting alpha-synuclein and uses thereof
‌
US Patent 11866696 Analytical HPLC methods
0
•••
Patent Inventor Names
Joseph Beene Bolen
0
Joshua P. Frederick
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10023626
0
Patent Primary Examiner
‌
Antonio Galisteo Gonzalez
0

Find more entities like US Patent 10023626 Polynucleotides encoding immune modulating polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo